Association of insulin-like growth factor-1 with thyroid nodules

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1297-1301

  Liu, Ying Jian ^a   Qiang, Wei ^a   Liu, Xing Jun ^a   Xu, Li ^a   Guo, Hui ^a   Wu, Li Ping ^a   Shi, Bingyin ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

IGF 1; Pathogenesis; Thyroid nodule

Indexed keywords

LIOTHYRONINE; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHYSICAL EXAMINATION; RADIOIMMUNOASSAY; THYROID ADENOMA; THYROID NODULE;

EID: 80052739316     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.411     Document Type: Article

References (41)

1. Carlson GW: Surgical anatomy of the neck. Surg Clin North Am 73: 837-852, 1993.
2. Alpay HC, Kalidag T, Keles E, Kaygusuz I, Yalcin S and Kapusuz Z: The effects of fine-needle biopsy on thyroid hormone levels. Otolaryngol Head Neck Surg 136: 942-945, 2007.
3. Welker MJ and Orlov D: Thyroid nodules. Am Fam Physician 67: 559-566, 2003.
4. Biersack HJ and Grunwald F: Thyroid cancer. N Engl J Med 345: 1216-1217, 2001.
5. LeRoith D and Roberts CT: Insulin-like growth factors. Ann N Y Acad Sci 692: 1-9, 1993.
6. Jones JI and Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34, 1995.
7. Jorgensen JO, Blum WF, Moller N, Ranke MB and Christiansen JS: Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age-and sex-matched normal subjects. Acta Endocrinol (Copenh) 123: 257-262, 1990.
8. Laughlin GA, Barrett-Connor E, Criqui MH and Kritz-Silverstein D: The prospective association of serum insulin-like growth factor1 (IGF-1) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo study. J Clin Endocrinol Metab 89: 114-120, 2004.
9. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM and Egger M: Insulin-like growth factor (IGF-1), IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353, 2004.
10. Geusens PP and Boonen S: Osteoporosis and the growth hormone-insulin-like growth factor axis. Horm Res 58 (Suppl3): 49-55, 2002.
11. Pollak MN, Schernhammer ES and Hankinson SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505-518, 2004.
12. Wu X, Zhao H, Ado K, et al: Serum levels of insulin growth factor (IGF-1) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res 10: 3988-3995, 2004.
13. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK and Roddam AW: Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11: 530-542, 2010.
14. Mucci LA, Stark JR, Pollak MN, Li H, Kurth T, Stampfer MJ and Ma J: Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 19: 484-491, 2010.
15. Yu H, Spitz MR, Mistry J, Gu J, Hong WK and Wu X: Plasma levels of insulin-like growth factor-1 and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91: 151-156, 1999.
16. Kimura T, van Keymeulen A, Golstein J, Fusco A, Dumont JE and Roger PP: Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22: 631-656, 2001.
17. Juul A, Holm K, Kastrup KW, et al: Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82: 2497-2502, 1997.
18. Zimmermann-Belsing T, Juul A, Juul Holst J and Feldt-Rasmussen U: The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment. Growth Horm IGFRes 14: 235-244, 2004.
19. Desser TS and Kamaya A: Ultrasound of thyroid nodules. Neuroimaging Clin NAm 18: 463-478, 2008.
20. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN and Society of Radiologists in Ultrasound: Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 237: 794-800, 2005.
21. Cappelli C, Pirola I, Cumetti D, et al: Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? Clin Endocrinol(Oxf) 63: 689-693, 2005.
22. Papini E, Guglielmi R, Bianchini A, et al: Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87: 1941-1946, 2002.
23. Sriram U and Patacsil LM: Thyroid nodules. Dis Mon 50: 486-526, 2004.
24. LeRoith D and Roberts CT: The insulin-like growth factor system and cancer. Cancer Lett 95: 127-137, 2003.
25. Shevah O and Laron Z: Patients with congenital deficiency of IGF-1 seem protected from the development of malignancies: a preliminary report. Growth Horm IGFRes 17: 54-57, 2007.
26. Tita P, Ambrosio MR, Scollo C, et al: High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63: 161-167, 2005.
27. Eszlinger M, Krohn K, Kratzsch J, Voigt C and Paschke R: Growth factor expression in cold and hot thyroid nodules. Thyroid 11: 125-135, 2001.
28. Völzke H, Friedrich N, Schipf S, et al: Association between serum insulin-like growth factor-1 levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab 92: 4039-4045, 2007.
29. Leifke E, Gorenoi V, Wichers C, von Zur Mühlen A, vonBüren E and Brabant G.: Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 53: 689-695, 2000.
30. Hsiao PJ and Tsai JH: Increased insulin-like growth factor-1 receptors in thyroid tissues of Graves' disease. J Formos Med Assoc 93: 925-32, 1994.
31. Surmacz E and Bartucci M: Role of estrogen receptoralpha in modulating IGF-I receptor signaling and function in breast cancer. J Exp Clin Cancer Res 23: 385-394, 2004.
32. Ingbar SH, Tramontano D and Amebesi-Impiombato S: Observations on the regulation of thyroid cell growth. Horm Metab Res Suppl 17: 43-51, 1987.
33. Ciampolillo A, de Tullio C and Giorgino F: The IGF-1/IGF-1 receptor pathway: implications in the pathophysiology of thyroid cancer. Curr Med Chem 12: 2881-2891, 2005.
34. Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK and Kumar R: Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res 13: 4291-4299, 2007.
35. Clemmons DR: Clinical utility of measurements of insulin-like growth factor1. Nat Clin Pract Endocrinol Metab 2: 436-446, 2006.
36. Clayton PE and Hall CM: Insulin-like growth factor I levels in healthy children. Horm Res 62 (Suppl1): 2-7, 2004.
37. Maes M, Underwood LE and Ketelslegers JM: Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Endocrinology 118: 377-382, 1986.
38. Kirschner BS and Sutton MM: Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91: 830-836, 1986.
39. Wu JC, Daughaday WH, Lee SD, et al: Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. JLab Clin Med 112: 589-594, 1988.
40. Foppiani L, Sulli A, Prete C, et al: Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients. Ann N Y Acad Sci 876: 83-87, 1999.
41. Hochberg Z: Mechanisms of steroid impairment of growth. Horm Res 58 (Suppl1): 33-38, 2002.